Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk

被引:139
作者
Baldini, EH
Goldberg, J
Jenner, C
Manola, JB
Demetri, GD
Fletcher, CDM
Singer, S
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Div Surg Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Ctr Sarcoma & Bone Oncol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Div Radiat Oncol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Div Biostat, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Div Med Oncol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dana Farber Canc Inst, Brigham & Womens Hosp,Div Pathol, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.1999.17.10.3252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To define the rate of local recurrence (LR) and identify prognostic factors for LR for patients with soft tissue sarcoma (STS) treated with function-sparing surgery (FSS) without radiotherapy (RT). Patients and Methods: Between 1970 and 1994, 242 patients with STS of the trunk and extremity presented with primary localized disease, 74 of whom were treated with FSS without RT (31%). The median tumor size was 4 cm (range, 0.5 to 31 cm), There were 40 patients with grade 1 tumors and 34 with grade 2 and 3 tumors. Median follow-up was 126 months. Results: The 10-year actuarial local control rate was 93% +/- 4%, Resection margin status was ct significant predictor for LR. patients with closest histologic resection margins of less than 1 cm herd a 10-year local control rate of 87% +/- 6% compared with 100% for patients with closest histologic resection margins of greater than or equal to 1 cm (P = .04). There was no significant association between LR and tumor grade, size, site (truncal v extremity), or depth (superficial v deep). For all patients, the 10-year actuarial survival rate was 73% +/- 6%. Conclusion: The 7% LR rate after treatment of STS with FSS without RT reported herein is comparable to published rates following treatment where adjuvant RT is used. These results suggest there may be a select subset of patients with STS in whom carefully per formed FSS may serve as definitive therapy and in whom adjuvant RT may not he necessary. However, further study is needed to carefully define this subset of patients and to identify the optimal surgical approach and technique for patients treated without RT. (C) 1999 by American Society of Clinical Oncology.
引用
收藏
页码:3252 / 3259
页数:8
相关论文
共 49 条
[1]  
[Anonymous], 1989, Analysis of binary data
[2]   TREATMENT OF SOFT-TISSUE SARCOMAS BY PREOPERATIVE IRRADIATION AND CONSERVATIVE SURGICAL RESECTION [J].
BARKLEY, HT ;
MARTIN, RG ;
ROMSDAHL, MM ;
LINDBERG, R ;
ZAGARS, GK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (04) :693-699
[3]   THE SURGICAL MARGIN IN SOFT-TISSUE SARCOMA [J].
BELL, RS ;
OSULLIVAN, B ;
LIU, FF ;
POWELL, J ;
LANGER, F ;
FORNASIER, VL ;
CUMMINGS, B ;
MICELI, PN ;
HAWKINS, N ;
QUIRT, I ;
WARR, D .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1989, 71A (03) :370-375
[4]   ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP [J].
BRAMWELL, V ;
ROUESSE, J ;
STEWARD, W ;
SANTORO, A ;
SCHRAFFORDTKOOPS, H ;
BUESA, J ;
RUKA, W ;
PRIARIO, J ;
WAGENER, T ;
BURGERS, M ;
VANUNNIK, J ;
CONTESSO, G ;
THOMAS, D ;
VANGLABBEKE, M ;
MARKHAM, D ;
PINEDO, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1137-1149
[5]  
Brennan M. F., 1997, PRINCIPLES PRACTICE, P1738
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]  
EILBER FR, 1984, CANCER, V53, P2579, DOI 10.1002/1097-0142(19840615)53:12<2579::AID-CNCR2820531202>3.0.CO
[8]  
2-V
[9]  
Fletcher CDM, 1998, MODERN PATHOL, V11, P1257
[10]   ON THE USE OF CAUSE-SPECIFIC FAILURE AND CONDITIONAL FAILURE PROBABILITIES - EXAMPLES FROM CLINICAL ONCOLOGY DATA [J].
GAYNOR, JJ ;
FEUER, EJ ;
TAN, CC ;
WU, DH ;
LITTLE, CR ;
STRAUS, DJ ;
CLARKSON, BD ;
BRENNAN, MF .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1993, 88 (422) :400-409